These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2377 related articles for article (PubMed ID: 23470321)

  • 81. Modulation of costimulation to enhance tumor immunity.
    Vesosky B; Hurwitz AA
    Cancer Immunol Immunother; 2003 Nov; 52(11):663-9. PubMed ID: 12920481
    [No Abstract]   [Full Text] [Related]  

  • 82. CD28 and CTLA-4 coreceptor expression and signal transduction.
    Rudd CE; Taylor A; Schneider H
    Immunol Rev; 2009 May; 229(1):12-26. PubMed ID: 19426212
    [TBL] [Abstract][Full Text] [Related]  

  • 83. B7-CTLA4 interaction promotes cognate destruction of tumor cells by cytotoxic T lymphocytes in vivo.
    Bai XF; Liu J; May KF; Guo Y; Zheng P; Liu Y
    Blood; 2002 Apr; 99(8):2880-9. PubMed ID: 11929778
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Immunosuppression through blockade of CD28:B7-mediated costimulatory signals.
    Judge TA; Tang A; Turka LA
    Immunol Res; 1996; 15(1):38-49. PubMed ID: 8739564
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Costimulation of IL-2 Production through CD28 Is Dependent on the Size of Its Ligand.
    Lim HS; Cordoba SP; Dushek O; Goyette J; Taylor A; Rudd CE; van der Merwe PA
    J Immunol; 2015 Dec; 195(11):5432-9. PubMed ID: 26500347
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Intact B7-H3 signaling promotes allograft prolongation through preferential suppression of Th1 effector responses.
    Ueno T; Yeung MY; McGrath M; Yang S; Zaman N; Snawder B; Padera RF; Magee CN; Gorbatov R; Hashiguchi M; Azuma M; Freeman GJ; Sayegh MH; Najafian N
    Eur J Immunol; 2012 Sep; 42(9):2343-53. PubMed ID: 22733595
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Searching for "signal 2": costimulation requirements of γδ T cells.
    Ribot JC; debarros A; Silva-Santos B
    Cell Mol Life Sci; 2011 Jul; 68(14):2345-55. PubMed ID: 21541698
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The evolution of the immunobiology of co-stimulatory pathways: clinical implications.
    Trikudanathan S; Sayegh MH
    Clin Exp Rheumatol; 2007; 25(5 Suppl 46):S12-21. PubMed ID: 17977484
    [TBL] [Abstract][Full Text] [Related]  

  • 89. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
    Zhou T; Weaver C; Linsley PS; Mountz JD
    Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
    [TBL] [Abstract][Full Text] [Related]  

  • 90. FcR cross-linking on monocytes results in impaired T cell stimulatory capacity.
    Barcy S; Wettendorff M; Leo O; Urbain J; Kruger M; Ceuppens JL; de Boer M
    Int Immunol; 1995 Feb; 7(2):179-89. PubMed ID: 7537534
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Signal transduction by CD28 costimulatory receptor on T cells. B7-1 and B7-2 regulation of tyrosine kinase adaptor molecules.
    Nunès JA; Truneh A; Olive D; Cantrell DA
    J Biol Chem; 1996 Jan; 271(3):1591-8. PubMed ID: 8576157
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.
    Freeman GJ; Gribben JG; Boussiotis VA; Ng JW; Restivo VA; Lombard LA; Gray GS; Nadler LM
    Science; 1993 Nov; 262(5135):909-11. PubMed ID: 7694363
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Emerging paradigms of T-cell co-stimulation.
    Kroczek RA; Mages HW; Hutloff A
    Curr Opin Immunol; 2004 Jun; 16(3):321-7. PubMed ID: 15134781
    [TBL] [Abstract][Full Text] [Related]  

  • 94. CTLA-4Ig: uses and future directions.
    Ben-Shoshan M
    Recent Pat Inflamm Allergy Drug Discov; 2009 Jun; 3(2):132-42. PubMed ID: 19519590
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Tumor necrosis factor-alpha and CD80 modulate CD28 expression through a similar mechanism of T-cell receptor-independent inhibition of transcription.
    Lewis DE; Merched-Sauvage M; Goronzy JJ; Weyand CM; Vallejo AN
    J Biol Chem; 2004 Jul; 279(28):29130-8. PubMed ID: 15128741
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Tyrosine phosphorylation of a novel 100-kDa protein coupled to CD28 in resting human T cells is enhanced by a signal through TCR/CD3 complex.
    Matsumoto A; Dobashi H; Ohnishi H; Tanaka T; Kubota Y; Kitanaka A; Ishida H; Tokuda M; Waki M; Kubo A; Ishida T
    Microbiol Immunol; 2003; 47(1):63-9. PubMed ID: 12636255
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?
    Croft M
    Nat Rev Immunol; 2003 Aug; 3(8):609-20. PubMed ID: 12974476
    [TBL] [Abstract][Full Text] [Related]  

  • 98. B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.
    Yadav D; Judkowski V; Flodstrom-Tullberg M; Sterling L; Redmond WL; Sherman L; Sarvetnick N
    J Immunol; 2004 Sep; 173(6):3631-9. PubMed ID: 15356107
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Immune checkpoint receptors in regulating immune reactivity in rheumatic disease.
    Ceeraz S; Nowak EC; Burns CM; Noelle RJ
    Arthritis Res Ther; 2014; 16(5):469. PubMed ID: 25606596
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Mathematical models of TCR initial triggering.
    Shi J; Yin W; Chen W
    Front Immunol; 2024; 15():1411614. PubMed ID: 39091495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 119.